TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2018

Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial.

Cindy Weinstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.